CN114366775A - Eye-protecting nutrient solution - Google Patents
Eye-protecting nutrient solution Download PDFInfo
- Publication number
- CN114366775A CN114366775A CN202011416260.9A CN202011416260A CN114366775A CN 114366775 A CN114366775 A CN 114366775A CN 202011416260 A CN202011416260 A CN 202011416260A CN 114366775 A CN114366775 A CN 114366775A
- Authority
- CN
- China
- Prior art keywords
- percent
- vitamin
- eye
- nutrient solution
- protecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 21
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940088594 vitamin Drugs 0.000 claims abstract description 13
- 229930003231 vitamin Natural products 0.000 claims abstract description 13
- 235000013343 vitamin Nutrition 0.000 claims abstract description 13
- 239000011782 vitamin Substances 0.000 claims abstract description 13
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 9
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 6
- 229960002477 riboflavin Drugs 0.000 claims abstract description 6
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims abstract description 4
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 4
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 4
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 4
- 229960003471 retinol Drugs 0.000 claims abstract description 4
- 235000020944 retinol Nutrition 0.000 claims abstract description 4
- 239000011607 retinol Substances 0.000 claims abstract description 4
- 239000002151 riboflavin Substances 0.000 claims abstract description 4
- 235000019192 riboflavin Nutrition 0.000 claims abstract description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract 2
- 229920001184 polypeptide Polymers 0.000 claims abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 2
- 239000000284 extract Substances 0.000 claims description 40
- 235000013399 edible fruits Nutrition 0.000 claims description 32
- 239000003814 drug Substances 0.000 claims description 25
- 235000008708 Morus alba Nutrition 0.000 claims description 18
- 240000000249 Morus alba Species 0.000 claims description 18
- 244000248825 Peltandra virginica Species 0.000 claims description 17
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 17
- 235000008599 Poria cocos Nutrition 0.000 claims description 17
- 229940045997 vitamin a Drugs 0.000 claims description 16
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 13
- 235000019155 vitamin A Nutrition 0.000 claims description 13
- 239000011719 vitamin A Substances 0.000 claims description 13
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 10
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 10
- 235000016709 nutrition Nutrition 0.000 claims description 10
- 229960002675 xylitol Drugs 0.000 claims description 10
- 235000010447 xylitol Nutrition 0.000 claims description 10
- 239000000811 xylitol Substances 0.000 claims description 10
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 10
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 9
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 9
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 9
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 9
- 229930003451 Vitamin B1 Natural products 0.000 claims description 9
- 229940107666 astragalus root Drugs 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 229960003495 thiamine Drugs 0.000 claims description 9
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 9
- 235000010374 vitamin B1 Nutrition 0.000 claims description 9
- 239000011691 vitamin B1 Substances 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 240000008067 Cucumis sativus Species 0.000 claims description 8
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 8
- 235000011511 Diospyros Nutrition 0.000 claims description 8
- 244000236655 Diospyros kaki Species 0.000 claims description 8
- 241001643642 Viticis Species 0.000 claims description 8
- 235000021015 bananas Nutrition 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000013355 food flavoring agent Nutrition 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 5
- 239000012676 herbal extract Substances 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 235000014443 Pyrus communis Nutrition 0.000 claims description 3
- 229930003756 Vitamin B7 Natural products 0.000 claims description 3
- 235000011912 vitamin B7 Nutrition 0.000 claims description 3
- 239000011735 vitamin B7 Substances 0.000 claims description 3
- 241000123846 Buddleja officinalis Species 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
- 229930003471 Vitamin B2 Natural products 0.000 claims description 2
- 229930003537 Vitamin B3 Natural products 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 2
- 235000019164 vitamin B2 Nutrition 0.000 claims description 2
- 239000011716 vitamin B2 Substances 0.000 claims description 2
- 235000019160 vitamin B3 Nutrition 0.000 claims description 2
- 239000011708 vitamin B3 Substances 0.000 claims description 2
- 235000019158 vitamin B6 Nutrition 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 244000182216 Mimusops elengi Species 0.000 claims 1
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 abstract description 2
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 abstract description 2
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 abstract description 2
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 abstract description 2
- 229920002414 procyanidin Polymers 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 29
- 230000004438 eyesight Effects 0.000 description 26
- 230000000694 effects Effects 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 11
- 235000007516 Chrysanthemum Nutrition 0.000 description 9
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 9
- 208000003464 asthenopia Diseases 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 240000002624 Mespilus germanica Species 0.000 description 8
- 230000035622 drinking Effects 0.000 description 8
- 240000005561 Musa balbisiana Species 0.000 description 7
- 241000220324 Pyrus Species 0.000 description 7
- 241001113925 Buddleja Species 0.000 description 6
- 235000021017 pears Nutrition 0.000 description 5
- 229960004793 sucrose Drugs 0.000 description 5
- 229930003270 Vitamin B Natural products 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 241001529821 Agastache Species 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 208000001140 Night Blindness Diseases 0.000 description 3
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 description 3
- 244000046095 Psophocarpus tetragonolobus Species 0.000 description 3
- 239000006286 aqueous extract Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000001525 retina Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 2
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 102000004330 Rhodopsin Human genes 0.000 description 2
- 108090000820 Rhodopsin Proteins 0.000 description 2
- 244000057717 Streptococcus lactis Species 0.000 description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 229940009291 bifidobacterium longum Drugs 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000021022 fresh fruits Nutrition 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000001328 optic nerve Anatomy 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000014733 refractive error Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000005494 xerophthalmia Diseases 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 241001412627 Adenophora liliifolia Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 235000000722 Celosia argentea Nutrition 0.000 description 1
- 240000008365 Celosia argentea Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010056677 Nerve degeneration Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 description 1
- 244000081426 Ranunculus ficaria Species 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 235000003713 Rhodiola rosea Nutrition 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 244000112814 pipewort Species 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- -1 vitamin a Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/44—Ebenaceae (Ebony family), e.g. persimmon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the technical field of health-care drinks, and particularly relates to eye-protecting nutrient solution. An eye-protecting nutrient solution comprises the following components in percentage by weight: 3-5% of hydrolyzed procyanidin, 4-5% of hydrolyzed vegetable protein, 1-2% of dipotassium glycyrrhizinate, 1-2% of riboflavin, 1-2% of retinol, 3-5% of soluble protein, 3-5% of vitamin, 1-2% of yeast polypeptide and the balance of water. The invention provides the eye-protecting nutrient solution which has low cost and simple production, is sprayed to eyes by an atomizer and has the functions of conditioning eyes of a human body and relieving fatigue.
Description
Technical Field
The invention belongs to the technical field of health-care spraying, and particularly relates to eye-protecting nutrient solution.
Background
Vision refers to the ability of the retina to resolve images. The quality of vision is determined by the amount of ability of the retina to resolve images, however, when the refractive medium of the eye (e.g., cornea, lens, vitreous, etc.) becomes cloudy or refractive errors (including myopia, hyperopia, astigmatism, etc.) exist, vision of the eye declines even when the retina functions well. Refractive media opacities of the eye can be treated surgically and refractive errors require correction by lenses.
With the development of society, the large-area popularization of electronic products brings about a plurality of vision problems, and the long-time use of eyes causes the problems of vision deterioration, eye fatigue, eye turbidity and the like of teenagers, middle-aged and even old people. The existing solutions mostly adopt means such as operations, drug therapy such as eye drops, and therapy of medical instruments to improve eyesight, and if people want to generate an eye protection effect through diet therapy in daily life, the effect is weak.
In view of the above problems, some vision nutrient solutions have been produced, such as the technical content disclosed in chinese patent CN 1041801C: a kind of eyesight nutrient solution, by rhizoma Dioscoreae, herba Agastaches, hyacinth bean, fructus Lycii, Poria, Mori fructus, flos Chrysanthemi, carrot aqueous extract concentrate, flavoring agent and water content make up, every component is counted according to the weight percent, aqueous extract concentrate 10-20%, flavoring agent 0.5-3% and water content 80-88%, wherein the aqueous extract concentrate contains crude drug amount 200 and 500g per 100 ml; the Chinese medicine composition is prepared with Chinese yam 10-20 wt%, agastache 6-10 wt%, hyacinth bean 10-20 wt%, wolfberry fruit 8-16 wt%, tuckahoe 8-16 wt%, mulberry 10-20 wt%, chrysanthemum 6-10 wt% and carrot 10-20 wt%.
Also as the technical content disclosed in chinese patent CN 108720024A: an active multi-enzyme vitamin cell nutrient solution contains fresh fruit pulp, tomato juice, carrot juice, glucose, fructo-oligosaccharide, lactobacillus powder, inulin, plant collagen, amino acid, vitamin E and vitamin C, wherein the fresh fruit pulp is selected from the following components: the lactobacillus powder is composed of lactobacillus acidophilus, lactobacillus casei, bifidobacterium longum, streptococcus thermophilus, lactococcus lactis and subsp lactis, wherein the mass ratio of the lactobacillus acidophilus to the lactobacillus casei to the bifidobacterium longum to the streptococcus thermophilus to the lactococcus lactis to the subsp lactis is 1:1:1:1: 1.
The technical content disclosed in the Chinese patent CN111558031A is as follows: the pure plant multifunctional eye special nutrient solution is characterized by comprising the following raw materials in parts by weight: 1.5 to 1 percent of angelica sinensis peptide, 0.5 to 1 percent of ginseng peptide, 0.5 to 1 percent of sea cucumber peptide, 0.5 to 1 percent of balsam pear peptide, 9 to 5 percent of astragalus root, 6 to 7 percent of rhodiola rosea, 5 to 4 percent of houttuynia cordata, 4 to 5 percent of peach kernel, 5 to 6 percent of safflower, 4 to 5 percent of kudzu root, 2 to 3 percent of root of straight ladybell, 3 to 2 percent of figwort root, 5 to 7 percent of salvia miltiorrhiza, 2 to 3 percent of wine-treated rhubarb, 4 to 5 percent of pipewort, 3 to 5 percent of mother of pearl, 3 to 2 percent of feather cockscomb seed, 4 to 5 percent of mulberry leaf, 5 to 2 percent of Huaihu chrysanthemum, 6 to 3 percent of mint, 5 to 2 percent of borneol, 3 to 4 percent of cassia seed, 3 to 4 percent of beta-carotene, 5 to 3 percent of lutein ester, 4-5% of taurine, 3-3% of vitamin B22, 3-2% of biotin, 2-2% of vitamin B31 and 1-2% of resveratrol.
Although the prior art is called to realize the function and effect of eye protection, the formula is too simple and old or too complex, the cost is higher, and the tea is not suitable for daily drinking.
Disclosure of Invention
The invention aims to provide the eye-protecting nutrient solution which has low cost and simple production, is sprayed to eyes by an atomizer and has the functions of conditioning eyes of a human body and relieving fatigue. In order to achieve the purpose, the invention adopts the following technical scheme:
an eye-protecting nutrient solution comprises the following components in percentage by weight:
3 to 5 percent of hydrolyzed procyanidine,
4 to 5 percent of hydrolyzed vegetable protein,
1 to 2 percent of dipotassium glycyrrhizinate,
1 to 2 percent of riboflavin,
1 to 2 percent of retinol,
3 to 5 percent of soluble protein,
3 to 5 percent of vitamin,
the balance of water.
On the basis of the technical scheme, the invention can also adopt the following further technical scheme:
specifically, the paint also comprises the following components in percentage by weight:
10 to 20 percent of traditional Chinese medicine extract,
15 to 30 percent of fruit extract,
5 to 10 percent of flavoring agent,
2 to 5 percent of vitamin,
the balance of water.
Specifically, the traditional Chinese medicine extract comprises the following components in percentage by weight:
3 to 5 percent of tuckahoe,
9 to 18 percent of Xiasangju,
15 to 25 percent of medlar,
15 to 25 percent of cassia seed,
1 to 3 percent of astragalus root,
12 to 20 percent of buddleja officinalis,
2 to 4 percent of fructus viticis,
the balance of water.
Wherein Poria has effects of promoting diuresis, eliminating dampness, invigorating spleen, and calming heart.
The main components of the prunella vulgaris, the mulberry leaf and the wild chrysanthemum flower. Spica Prunellae enters liver and gallbladder meridians, integrates pure yang qi, nourishes liver-related jueyin blood vessels, treats yin with yang, is a "holy drug" for clearing and protecting liver, folium Mori is good at calming liver wind, leaves are fragrant and also moves through lung collaterals to ventilate lung qi. Has the effects of dispelling wind and heat, clearing lung-heat, moistening dryness, removing liver fire and improving eyesight. The wild chrysanthemum flower is fragrant and sweet in taste, can tonify the two internal organs of the body, calm the liver, improve eyesight, clear heat and remove toxicity.
The medlar contains rich carotene, vitamin A, B1, B2, C, calcium, iron and the like, and is necessary nutrition for healthy eyes.
Semen Cassiae has effects of removing liver fire, improving eyesight, and loosening bowel to relieve constipation.
Radix astragali has effects of invigorating qi, consolidating superficial resistance, expelling toxin, expelling pus, promoting urination, and promoting granulation.
Flos Buddlejae is slightly cold in nature and sweet in taste, enters liver channel, has effects of clearing heat, nourishing liver, improving eyesight and removing nebula, and can be used for treating conjunctival congestion, swelling and pain, lacrimation, photophobia, nebula, liver deficiency, dim eyesight and blurred vision, and is a common medicine for ophthalmology.
Chastetree fruit is commonly used for headache due to exogenous pathogenic factors, dizziness, blurred vision, hyperdacryosis, pain in eyes, swelling and pain of gum, and spasm due to damp arthralgia.
Specifically, the fruit extract comprises the following components in percentage by weight:
5 to 8 percent of cucumber,
15% -20% of bananas,
8 to 15 percent of pear,
18 to 25 percent of persimmon,
20% -25% of oranges,
3 to 7 percent of mulberry,
the balance of water.
The fruits are rich in vitamin A, and can protect eye tissue and structure, maintain normal efficacy of rhodopsin of eye, and prevent and treat nyctalopia and xerophthalmia.
Specifically, the flavoring agent is xylitol or sucrose, so that the taste of the nutrient solution can be optimized.
Specifically, the vitamin is one or more of vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin C, and vitamin H. Vitamin A can protect eye tissue, structure, maintain normal function of rhodopsin, and prevent and treat nyctalopia and xerophthalmia. Vitamin B1 has effects in protecting optic nerve, maintaining normal vision, preventing optic nerve degeneration, and preventing cataract and other eye diseases.
Specifically, when the vitamins are vitamin A and vitamin B1, the mass ratio of the vitamin A to the vitamin B1 is 32: 45.
the invention has the following technical characteristics: the eye-protecting nutrient solution disclosed by the invention can be prepared by supplementing food materials and Chinese medicinal materials together from the simultaneous administration of food supplement and medicine supplement through the scientific proportion of the Chinese medicaments and the fruits, so that the respective effects are better exerted, the effect of helping the eyesight during daily drinking is realized, and the eye-protecting effects of relieving eye fatigue, clearing liver and improving eyesight, improving nyctalopia and the like can be realized.
Detailed Description
The following specific examples are further illustrative of the methods and techniques provided by the present invention and should not be construed as limiting the invention thereto.
The first embodiment of the invention provides an eye-protecting nutrient solution, which comprises the following components in percentage by weight:
10 percent of the traditional Chinese medicine extract,
15 percent of fruit extract,
5 percent of xylitol,
2 percent of vitamin A,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
3 percent of tuckahoe, namely tuckahoe,
9 percent of summer mulberry and chrysanthemum,
15 percent of the medlar,
15 percent of cassia seed,
1 percent of astragalus root,
12 percent of the pale butterflybush flower,
2 percent of fructus viticis,
the balance of water.
Wherein the fruit extract comprises the following components in percentage by weight:
5 percent of cucumber,
15 percent of the bananas,
8 percent of pear,
18 percent of persimmon,
20 percent of the orange peel is added,
3 percent of mulberry fruit,
the balance of water.
In this embodiment, the eye-protecting nutritional liquid is prepared by mixing the herbal extract, the fruit extract and water, and then adding xylitol and vitamin a to the mixture.
The second embodiment provides an eye-protecting nutrient solution, which comprises the following components in percentage by weight:
20 percent of traditional Chinese medicine extract,
30 percent of fruit extract,
10 percent of xylitol,
the vitamin B is 15 percent,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
5 percent of tuckahoe, namely,
18 percent of summer mulberry and chrysanthemum,
25 percent of the medlar,
25 percent of cassia seed,
3 percent of astragalus root,
20 percent of the butterflybush flower,
4 percent of fructus viticis.
Wherein the fruit extract comprises the following components in percentage by weight:
8 percent of cucumber,
20 percent of the bananas,
15 percent of pears,
25 percent of persimmon,
25 percent of the orange peel is added,
7% of mulberry.
In this embodiment, the eye-protecting nutritional liquid is prepared by mixing the herbal extract, the fruit extract and water, and then adding xylitol and vitamin B1 to mix.
In the third embodiment, the eye-protecting nutrient solution comprises the following components in percentage by weight:
15 percent of traditional Chinese medicine extract,
20 percent of fruit extract,
8 percent of cane sugar,
3 percent of vitamin A, and the like,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
4 percent of tuckahoe, namely tuckahoe, the weight percentage of tuckahoe,
12 percent of summer mulberry and chrysanthemum,
20 percent of the medlar,
20 percent of cassia seed,
2 percent of astragalus root,
18 percent of the butterflybush flower,
3 percent of fructus viticis,
the balance of water.
Wherein the fruit extract comprises the following components in percentage by weight:
7 percent of cucumber,
18 percent of the bananas,
12 percent of pears,
20 percent of persimmon,
25 percent of the orange peel is added,
5 percent of mulberry fruit,
the balance of water.
In this embodiment, the eye-protecting nutritional liquid is prepared by mixing the herbal extract, the fruit extract, sucrose, vitamin a, and water together.
The fourth embodiment provides an eye-protecting nutrient solution, which comprises the following components in percentage by weight:
15 percent of traditional Chinese medicine extract,
20 percent of fruit extract,
8 percent of cane sugar,
the vitamin B is 13 percent,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
4 percent of tuckahoe, namely tuckahoe, the weight percentage of tuckahoe,
12 percent of summer mulberry and chrysanthemum,
22 percent of the medlar,
20 percent of cassia seed,
2 percent of astragalus root,
19 percent of the pale butterflybush flower,
3 percent of fructus viticis,
the balance of water.
Wherein the fruit extract comprises the following components in percentage by weight:
7 percent of cucumber,
18 percent of the bananas,
12 percent of pears,
19 percent of persimmon,
25 percent of the orange peel is added,
5 percent of mulberry fruit,
the balance of water.
In this embodiment, the eye-protecting nutritional liquid is prepared by mixing the herbal extract, the fruit extract, sucrose, vitamin B1, and water.
The fifth embodiment provides an eye-protecting nutrient solution, which comprises the following components in percentage by weight:
18 percent of the traditional Chinese medicine extract,
25 percent of fruit extract,
7 percent of xylitol,
4 percent of vitamin A,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
3 percent of tuckahoe, namely tuckahoe,
16 percent of summer mulberry and chrysanthemum,
21 percent of the medlar,
18 percent of cassia seed,
1 percent of astragalus root,
18 percent of the butterflybush flower,
3 percent of fructus viticis,
the balance of water.
Wherein the fruit extract comprises the following components in percentage by weight:
8 percent of cucumber,
19 percent of the bananas,
14 percent of pears,
23 percent of persimmon,
25 percent of the orange peel is added,
5 percent of mulberry fruit,
the balance of water.
In this embodiment, the preparation method of the eye-protecting nutritional liquid is to mix the traditional Chinese medicine extract and the fruit extract, and then add xylitol, vitamin a and water to mix them together.
The sixth embodiment provides an eye-protecting nutrient solution, which comprises the following components in percentage by weight:
5 percent of hydrolyzed procyanidin,
5 percent of hydrolyzed vegetable protein,
2 percent of dipotassium glycyrrhizinate,
1 percent of riboflavin,
2 percent of retinol,
3 percent of soluble protein,
1 percent of vitamin H,
18 percent of the traditional Chinese medicine extract,
25 percent of fruit extract,
7 percent of xylitol,
4 percent of vitamin A,
the vitamin B is 21 percent,
the vitamin B is 61 percent,
1 percent of folic acid,
1 percent of vitamin C,
the balance of water.
Wherein, the traditional Chinese medicine extract comprises the following components in percentage by weight:
3 percent of tuckahoe, namely tuckahoe,
16 percent of summer mulberry and chrysanthemum,
21 percent of the medlar,
18 percent of cassia seed,
1 percent of astragalus root,
18 percent of the butterflybush flower,
3 percent of fructus viticis,
the balance of water.
Wherein the fruit extract comprises the following components in percentage by weight:
8 percent of cucumber,
19 percent of the bananas,
14 percent of pears,
23 percent of persimmon,
25 percent of the orange peel is added,
5 percent of mulberry fruit,
the balance of water.
In this embodiment, the preparation method of the eye-protecting nutritional liquid is to mix the traditional Chinese medicine extract and the fruit extract, and then add xylitol, all vitamins and water to mix them together.
The vision nutrient solution comprises the following components in percentage by weight:
10 to 20 percent of water extract concentrated solution,
0.5 to 3 percent of flavoring agent,
80 to 88 percent of water,
wherein the water extraction concentrated solution contains 500g of crude drug in 200 g per 100 ml;
the Chinese medicine composition is prepared with Chinese yam 10-20 wt%, agastache 6-10 wt%, hyacinth bean 10-20 wt%, wolfberry fruit 8-16 wt%, tuckahoe 8-16 wt%, mulberry 10-20 wt%, chrysanthemum 6-10 wt% and carrot 10-20 wt%.
In contrast tests, 120 myopic volunteers are selected, the age interval is 18-60 years, and half of male and female are selected, 20 volunteers of different ages are selected from the nutrient solution prepared by the five embodiments and one comparative example, the nutrient solution continuously drinks 200ML at 10 am every day, the vision of the volunteers is continuously drunk for 6 months and collected at half a month intervals, the average value of the vision change of the 20 volunteers in the 6 months is obtained, and the test results are as follows:
the vision of the volunteers drinking the eye-protecting nutrient solution of the first embodiment is not changed on average, but the volunteers with the age level of 30-40 years show improvement of eye fatigue;
the volunteers who drunk the eye-protecting nutrient solution of example two had no change in their eyesight on average, but each volunteer showed all improvement in eye fatigue;
the vision of the volunteers drinking the eye-protecting nutrient solution of the third embodiment is improved by 25 degrees on average, and each volunteer shows all improvements of eye fatigue;
the vision of the volunteers drinking the eye-protecting nutrient solution of the fourth example is not changed on average, but the volunteers aged 30-60 years show improvement of eye fatigue;
the vision of the volunteers drinking the eye-protecting nutrient solution of the fifth embodiment is not changed on average, but the volunteers with the age level of 40-60 years show improvement of eye fatigue;
the vision of the volunteers drinking the eye-protecting nutrient solution of the sixth embodiment is improved by 25 degrees on average, and each volunteer shows all improvements of eye fatigue;
the vision of the volunteers drinking the eye-protecting nutrient solution of the comparative example did not change on average, and two volunteers showed improvement in eye fatigue.
As can be seen from the above tests, the eye protection effect of the third embodiment is the best, and the fatigue of eyes is relieved in all of the first to fifth embodiments.
The above description of the embodiments is only intended to facilitate the understanding of the method of the invention and its core ideas. It should be noted that, for those skilled in the art, it is possible to make various improvements and modifications to the present invention without departing from the principle of the present invention, and those improvements and modifications also fall within the scope of the claims of the present invention.
Claims (7)
1. The eye-protecting nutrient solution is characterized by comprising the following components in percentage by weight:
3 to 5 percent of hydrolyzed procyanidine,
4 to 5 percent of hydrolyzed vegetable protein,
1 to 2 percent of dipotassium glycyrrhizinate,
1 to 2 percent of riboflavin,
1 to 2 percent of retinol,
3 to 5 percent of soluble protein,
3 to 5 percent of vitamin,
1 to 2 percent of yeast polypeptide,
the balance of water.
2. The eye-protecting nutrient solution according to claim 1, characterized by further comprising the following components in percentage by weight:
10 to 20 percent of traditional Chinese medicine extract,
15 to 30 percent of fruit extract,
5 to 10 percent of flavoring agent,
2 to 5 percent of vitamin,
the balance of water.
3. The eye-protecting nutrient solution as claimed in claim 2, wherein the Chinese herbal extract comprises the following components in percentage by weight:
3 to 5 percent of tuckahoe,
9 to 18 percent of Xiasangju,
15 to 25 percent of medlar,
15 to 25 percent of cassia seed,
1 to 3 percent of astragalus root,
12 to 20 percent of buddleja officinalis,
2 to 4 percent of fructus viticis,
the balance of water.
4. An eye-care nutritional liquid according to claim 2, wherein the fruit extract comprises the following components in percentage by weight:
5 to 8 percent of cucumber,
15% -20% of bananas,
8 to 15 percent of pear,
18 to 25 percent of persimmon,
20% -25% of oranges,
3 to 7 percent of mulberry,
the balance of water.
5. An eye-care nutritional liquid according to claim 1, wherein said flavoring agent is xylitol or sucrose.
6. An eye-protecting nutritional liquid according to claim 1, wherein said vitamin is one or more of vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin C, and vitamin H.
7. The nutrient solution as claimed in claim 6, wherein when the vitamins are vitamin A and vitamin B1, the mass ratio of vitamin A to vitamin B1 is 32: 45.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011416260.9A CN114366775A (en) | 2020-12-07 | 2020-12-07 | Eye-protecting nutrient solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011416260.9A CN114366775A (en) | 2020-12-07 | 2020-12-07 | Eye-protecting nutrient solution |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114366775A true CN114366775A (en) | 2022-04-19 |
Family
ID=81138671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011416260.9A Pending CN114366775A (en) | 2020-12-07 | 2020-12-07 | Eye-protecting nutrient solution |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114366775A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115282218A (en) * | 2022-06-28 | 2022-11-04 | 深圳市艾普生物科技有限公司 | Herbal atomized composition for relieving eye fatigue and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1088455A (en) * | 1993-10-21 | 1994-06-29 | 徐晓东 | Nutrition solution for vision care |
US20160151437A1 (en) * | 2014-06-02 | 2016-06-02 | Viva Pharmaceutical, Inc. | Nutritional supplements for improved vision and methods of treating the same |
CN108720024A (en) * | 2018-05-02 | 2018-11-02 | 威海养经堂医药科技有限公司 | A kind of activity multienzyme vitamin cell nutrient solution |
CN108992544A (en) * | 2018-09-12 | 2018-12-14 | 西安力邦制药有限公司 | A kind of Chinese medicine composition for preventing and treating eye disease |
CN110025672A (en) * | 2019-05-17 | 2019-07-19 | 李文燕 | A kind of juvenile shortsightedness accommodation cream and preparation method thereof |
CN111558031A (en) * | 2020-05-13 | 2020-08-21 | 河南钎艺食品有限公司 | Pure plant multifunctional eye special nutrient solution and preparation method thereof |
CN111821355A (en) * | 2020-08-06 | 2020-10-27 | 河北康平健康产业有限责任公司 | Eyesight-protecting lycium ruthenicum and lutein chewable tablet and preparation method thereof |
-
2020
- 2020-12-07 CN CN202011416260.9A patent/CN114366775A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1088455A (en) * | 1993-10-21 | 1994-06-29 | 徐晓东 | Nutrition solution for vision care |
US20160151437A1 (en) * | 2014-06-02 | 2016-06-02 | Viva Pharmaceutical, Inc. | Nutritional supplements for improved vision and methods of treating the same |
CN108720024A (en) * | 2018-05-02 | 2018-11-02 | 威海养经堂医药科技有限公司 | A kind of activity multienzyme vitamin cell nutrient solution |
CN108992544A (en) * | 2018-09-12 | 2018-12-14 | 西安力邦制药有限公司 | A kind of Chinese medicine composition for preventing and treating eye disease |
CN110025672A (en) * | 2019-05-17 | 2019-07-19 | 李文燕 | A kind of juvenile shortsightedness accommodation cream and preparation method thereof |
CN111558031A (en) * | 2020-05-13 | 2020-08-21 | 河南钎艺食品有限公司 | Pure plant multifunctional eye special nutrient solution and preparation method thereof |
CN111821355A (en) * | 2020-08-06 | 2020-10-27 | 河北康平健康产业有限责任公司 | Eyesight-protecting lycium ruthenicum and lutein chewable tablet and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
"电脑族护眼8大食物", 《中国眼镜科技杂志》 * |
侯岩: "中药治疗干眼症的临床研究", 《中国社区医师(医学专业)》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115282218A (en) * | 2022-06-28 | 2022-11-04 | 深圳市艾普生物科技有限公司 | Herbal atomized composition for relieving eye fatigue and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101926483A (en) | Medlar and chrysanthemum eyesight-improving intelligence-developing health care drink | |
CN101700365A (en) | Functional beverage for improving vision | |
CN101269153A (en) | Sobering-up composition and preparation method thereof | |
CN108606190A (en) | A kind of blueberry draft composite plant beverage, preparation method and application | |
CN105362501A (en) | Radiation-preventing and eyesight-protecting beverage, and preparation method thereof | |
CN102443528B (en) | Wolfberry yam wine and preparation method thereof | |
CN104187914A (en) | Red pomegranate juice beverage and preparation method thereof | |
CN101869162A (en) | Glossy ganoderma tea and preparation method thereof | |
CN105031238A (en) | Maca traditional Chinese medicine health wine and brewing method thereof | |
CN105878812B (en) | Hangover alleviating beverage prepared from Camellia chrysantha and herba Dendrobii, and its preparation method | |
CN104207241B (en) | A kind of integration of drinking and medicinal herbs composite health care beverage and preparation method thereof | |
CN105441281A (en) | Health wine capable of reinforcing kidney to strengthen yang and preparation method of health wine | |
CN103349121B (en) | Hyperglycemia-hyperlipidemia-hypertension relieving health protection tea and preparation method thereof | |
CN106387591A (en) | Chlorella and green plant juice powder solid beverage | |
CN114366775A (en) | Eye-protecting nutrient solution | |
CN103141638B (en) | Eight-treasure tea for male | |
CN106509526B (en) | Coarse cereal fruit juice and preparation method thereof | |
CN101228958A (en) | Method of extracting amylose and red-yellow pigment from medlar as accretion used for rhodiola rosea beverage | |
CN105410243A (en) | Healthcare tea for health preservation in four seasons | |
CN114432384A (en) | Deuterium-depleted borneol atomized eye protection liquid | |
CN103829240B (en) | A kind of containing Pericarpium Longan, the health product improving acuity of vision and preparation method thereof of core lixiviating solution | |
CN113243516A (en) | Soy sauce with blood sugar regulating effect | |
CN102894449A (en) | Solid beverage capable of beautifying and preparation method thereof | |
CN107149014A (en) | Antipyretic beverage that a kind of suitable insomnia crowd drinks and preparation method thereof | |
CN1286964C (en) | Wolfberry recupration wine and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220419 |
|
RJ01 | Rejection of invention patent application after publication |